Anal melanoma, Clin Colon Rectal Surg, vol.19, issue.2, pp.78-87, 2006. ,
Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin, Melanoma Res, vol.19, issue.1, pp.58-60, 2009. ,
Primary anorectal malignant melanomas within a population-based national patient series in Sweden during 40 years, Acta Oncol, vol.48, issue.1, pp.125-156, 2009. ,
Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center, Dis Colon Rectum, vol.38, issue.2, pp.146-51, 1995. ,
Anorectal melanoma: review of 22 consecutive cases, Hepatogastroenterology, vol.60, issue.121, pp.89-93, 2013. ,
Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience, Cancer, vol.117, issue.20, pp.4747-55, 2011. ,
Primary malignant melanoma of the rectum: CT findings in eight patients, Radiology, vol.232, issue.1, pp.181-187, 2004. ,
Checkpoint inhibition for advanced mucosal melanoma, Eur J Dermatol, vol.27, issue.2, pp.160-165, 2017. ,
Improved overall survival in melanoma with combined dabrafenib and trametinib, N Engl J Med, vol.372, issue.1, pp.30-39, 2015. ,
The efficacy of anti-PD-1 agents in acral and mucosal melanoma, Cancer, vol.122, issue.21, pp.3354-62, 2016. ,
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma, Ann Oncol, vol.28, issue.7, pp.1605-1616, 2017. ,
Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1/PD-L1, Clin Cancer Res, vol.23, issue.8, pp.1920-1928, 2017. ,
Promising cancer drugs may speed tumours in some patients, Nature, vol.544, issue.7648, pp.13-17, 2017. ,
,
, Soins Gerontol, vol.22, issue.127, pp.30-33, 2017.
Myeloid-derived suppressor cells, Cancer Immunol Res, vol.5, issue.1, pp.3-8, 2017. ,
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response, Nature, vol.545, issue.7652, pp.60-65, 2017. ,
Genomics of immunotherapy-associated hyperprogressorsresponse, Clin Cancer Res, vol.23, issue.20, p.6376, 2017. ,
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy, Nat Med, vol.24, issue.2, pp.144-53, 2018. ,
Monocyte differentiation and antigen-presenting functions, Nat Rev Immunol, vol.17, issue.6, pp.349-62, 2017. ,
Viral acute lower respiratory infections impair CD8+ T cells through PD-1, J Clin Invest, vol.122, issue.8, pp.2967-82, 2012. ,